Connor, Clark & Lunn Investment Management Ltd.

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1596800 VANCOUVER, A1

Position in FULC

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,727,860

-$2,922,506 QoQ

Shares Held

745,317

+1.2% QoQ

Ownership

0.977%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#31

of 154 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $650,455,383 across 105 Biotechnology names. FULC ranks #42 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	135,236	$67,175,777
2	IONS	Ionis Pharmaceuticals Inc	684,236	$54,253,072
3	ARWR	Arrowhead Pharmaceuticals, Inc.	625,569	$50,990,129
4	MIRM	Mirum Pharmaceuticals, Inc.	420,063	$49,176,775
5	REGN	Regeneron Pharmaceuticals, Inc.	42,465	$26,478,625
6	AXSM	Axsome Therapeutics, Inc.	97,698	$23,913,539
7	INSM	INSMED Inc	212,676	$22,675,515
8	VKTX	Viking Therapeutics, Inc.	530,607	$20,698,979

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,727,860	745,317	+1.2%	Shares	Sole	2026-08-13
2026-03-31	$5,650,366	736,684	+26.5%	Shares	Sole	2026-05-11
2025-12-31	$6,586,683	582,377	+51.6%	Shares	Sole	2026-02-10
2025-09-30	$3,534,069	384,138	+12.1%	Shares	Sole	2025-11-13
2025-06-30	$2,356,723	342,547	+57.3%	Shares	Sole	2025-08-07
2025-03-31	$627,117	217,749	-40.8%	Shares	Sole	2025-05-12
2024-12-31	$1,727,691	367,594	+176.8%	Shares	Sole	2025-02-10
2024-09-30	$474,038	132,784	—	Shares	Sole	2024-11-08
No filing history on record for this holder in this stock.